ATRA vs DRI · rev $128.9M vs P/E 22, rev $12.08B
Atara Biotherapeutics Inc (ATRA) versus Darden Restaurants Inc (DRI) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported DRI revenue for 2025-05-25 was $12.08B. Net income was $1.05B. Revenue was up 6.0% from 2024-05-26 to 2025-05-25. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
ATRA currently screens at market cap $87.1M. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
Not investment advice. Open the ATRA and DRI stock pages for the full models.
Not investment advice.